Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting-Reference-Cited by-同舟云学术

Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting

Published:2018-06 Issue:3 Volume:16 Page:e605-e612
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Verbiest Annelies^ORCID,Couchy Gabrielle,Job Sylvie,Zucman-Rossi Jessica,Caruana Laure,Lerut Evelyne,Oyen Raymond,de Reyniès Aurélien,Laguerre Brigitte,Rioux-Leclercq Nathalie,Wozniak Agnieszka,Joniau Steven,Van Poppel Hendrik,Van Den Eynde Kathleen,Beuselinck Benoit

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference31 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2016

3. Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology;Motzer;J Natl Compr Canc Netw,2017

4. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

5. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent gene mutations and the correlations with clinicopathological features in clear cell renal cell carcinoma: preliminary study based on Chinese population and TCGA database;BMC Urology;2024-08-09

2. DNA Methylation as Drug Sensitivity Marker in RCC: A Systematic Review;Epigenomes;2024-07-15

3. Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study;Cancer Reports;2024-06

4. Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?;Cancer Medicine;2024-06

5. Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC);ESMO Real World Data and Digital Oncology;2024-03